SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

Add KTOV Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/21/2017 12:02:14 PM - Followers: 116 - Board type: Free - Posts Today: 0



US Office

1615 Suter’s Lane NW, Washington DC 20007, Tel:  +1-202-965-2215

Israel Office

One Azrieli Center, Round Tower, Tel Aviv 6701101


Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs
that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Kitov is developing combination drug products that treat the pain of osteoarthritis without causing cardiovascular problems.
These drugs will not only not need to be labeled with health warnings, but will actually be labeled as reducing the risk of
cardiovascular events. Kitov’s drugs have the potential to improve the health of millions of patients worldwide.
It is expected that physicians will prefer to prescribe them rather than prescribe two separate drugs, to improve their patients’ health and to reduce their own legal exposure.

Kitov is currently focusing two late-stage drugs. Both contain NSAIDs that are widely consumed throughout the world for treating osteoarthritis.
Each of Kitov’s drugs adds to the NSAID a second drug product that reduces hypertension.

KIT-301: Naproxen combined with anti-hypertension. Ready for phase III clinical trial. New Drug Application (NDA) scheduled
for 20-24 months from start of development.
KIT-302: Celecoxib combined with anti-hypertension. Ready for phase III clinical trial. New Drug Application (NDA) scheduled for 2015.

Osteoarthritis, affecting approximately half of all adults over the age of 50, is a degenerative disease of joints that can cause pain and limit mobility.
Exercise and weight control are important therapies for controlling symptoms, but for many patients medication is the next step in pain treatment.
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used medications for treating osteoarthritis pain.
However, these medications raise blood pressure (hypertension) and thereby increase the risk of heart attacks, strokes, and death.
This has led the US FDA to require including a black box warning in the labeling of all NSAIDs, warning of these increased cardiovascular risks.


Dr. John Paul Waymack – M.D., Sc.D.

Chairman of the Board of Directors and Chief Medical Officer

Dr. Waymack was one of the founders of Kitov Pharmaceuticals and has served as the Chairman of our Board of Directors and Chief Medical Officer since July 2013. Dr. Waymack has over 20 years of experience in the biopharma field. Dr. Waymack is a former academic transplant surgeon and a former FDA medical officer, with over fifteen years of experience in drug development as a consultant to major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10 years of academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. In addition, Dr. Waymack volunteered to the U.S. army, where he was commissioned and served as a Major in the Medical Corp. in the position of Chief of Surgical Research in the U.S. Army’s Institute for Surgical Research. Dr. Waymack was also an associate professor of surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey.



Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302

November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing

October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
KTOV News: Report of Foreign Issuer (6-k) 04/03/2017 06:59:52 AM
KTOV News: Report of Foreign Issuer (6-k) 03/27/2017 05:20:25 PM
KTOV News: Report of Foreign Issuer (6-k) 03/17/2017 04:03:37 PM
KTOV News: Report of Foreign Issuer (6-k) 03/08/2017 09:01:22 AM
KTOV News: Report of Foreign Issuer (6-k) 03/03/2017 06:07:34 AM
#5559   Still believing in the science and in Waymack. Good EM 04/21/17 12:02:14 PM
#5558   Hope so GLTU! tmeier 04/21/17 11:51:43 AM
#5557   Not sure at all. Lot of catalysts in EM 04/21/17 11:23:51 AM
#5556   The problem is its gonna take alot of time. tmeier 04/21/17 11:18:29 AM
#5555   Just a matter of time. Bomb will explode EM 04/20/17 05:15:01 PM
#5554   Where's all the action? Still holding looking for riverterracekrew 04/20/17 01:32:19 PM
#5553   Thanks you are right just checked Nasdaq Masala 04/18/17 08:42:22 AM
#5552   The Company’s securities (American Depository Shares (“ADS”) as Rymankoly 04/17/17 11:33:00 PM
#5551   The Bank of New York Mellon, as depositary, Rymankoly 04/17/17 11:29:21 PM
#5550   The shares on th exchange are already bundled Masala 04/17/17 11:11:52 PM
#5549   170,000,000 is about 8.5MM ADR (1:20) Rymankoly 04/17/17 08:37:52 PM
#5548   170,000,000 shares who said small float? Masala 04/17/17 07:05:21 PM
#5546   Trading is truncated during mid-holidays of Passover (April 12-13) ash111 04/11/17 03:36:35 PM
#5545   KTOV Solid DD,JB3729. Once approved, KIT-302 will be ash111 04/11/17 12:22:24 PM
#5544   I think we got a real flyer, looks Masala 04/10/17 05:05:09 PM
#5543   risk/ thinks reward in time.What makes this company ash111 04/10/17 04:37:52 PM
#5542   Hopefully that is the case! tmeier 04/10/17 04:34:27 PM
#5541   Thanks. Calm before the storm. ash111 04/10/17 01:37:36 PM
#5540   No TASE today, Apr 10th midastouch017 04/10/17 05:21:35 AM
#5539   Sure.NDA for a billion dollar Drug could hit ash111 04/10/17 03:59:48 AM
#5538   Yap.will be fun to watch it. ash111 04/10/17 03:53:39 AM
#5537   What's the DD on this, company is mixing Masala 04/09/17 07:26:53 PM
#5536   7mm ADS float. It just needs the right news. EM 04/09/17 04:58:16 PM
#5535   Good DD. License Agreement for KIT-302 in South ash111 04/09/17 03:05:12 PM
#5534   Shorting at a bottom is just plain stupid!!! tmeier 04/09/17 11:22:18 AM
#5533   People pay for their mistakes. midastouch017 04/09/17 10:55:34 AM
#5532   Lack of DD doesn't allow you to catch EM 04/09/17 04:19:51 AM
#5531   I wouldn't short a debt Free stock w/ ash111 04/09/17 02:53:44 AM
#5530   Only time will tell... Shorts and Puts have Masala 04/08/17 09:51:08 PM
#5529   KTOV My advice to you, ash111 04/08/17 03:03:14 PM
#5525   Wow you really good at repeating old news tmeier 04/06/17 04:25:49 AM
#5524   Yeah you got a real wants to Masala 04/05/17 11:45:01 PM
#5523   Pathetic DD HeresJonny 04/05/17 11:36:24 PM
#5522   A combo pill is a marketing ploy Masala 04/05/17 10:46:19 PM
#5521   All Nonsteroidal anti-inflammatory drugs have a risk of Masala 04/05/17 10:34:40 PM
#5520   Also it's about compliance. As an MD, compliance Nojunk 04/05/17 10:16:30 PM
#5519   Agree there will still be warnings, but one RBNEWS 04/05/17 08:17:52 PM
#5518   both pills have active ingredients with side effects....there Masala 04/05/17 06:04:41 PM
#5517   May as well. 10 cents a page. scottsmith 04/05/17 05:38:40 PM
#5516   Looking at his post I think he would EM 04/05/17 05:38:00 PM
#5515   Thanks, I may sign up. RBNEWS 04/05/17 05:35:13 PM
#5514   So, what if right next to what you RBNEWS 04/05/17 05:28:33 PM
#5513   I have a Pacer account. You can scottsmith 04/05/17 05:23:22 PM
#5512   What's so important about this generic combination therapy, Masala 04/05/17 05:18:21 PM
#5511   Hi Scottsmith, seen your stocktwits post about stonewalling. RBNEWS 04/05/17 04:57:11 PM
#5510   According to Tase, KTOV's weight cap factor(This factor ash111 04/04/17 01:13:01 PM
#5509   Masala 04/04/17 02:19:14 AM
#5508   I personally do not believe it's dexcel. RBNEWS 04/03/17 05:07:54 PM
#5507   Waiver has nothing to do w/ delay. scottsmith 04/03/17 04:27:07 PM
#5506   Capturing the $2MM waiver would be a very nsomniyak 04/03/17 04:24:55 PM